Narrow Results Clear All
Search results for "Government Resource"
FDA Safety Communication. Silver Spring, MD: US Food and Drug Administration; February 25, 2015.
The practice of using multi-dose insulin pens, meant for single patient use only, among multiple patients has been linked to health care–associated infections. This announcement outlines federal labeling requirements to raise awareness of the risks associated with this practice to prevent misuse of the devices.
Journal Article > Commentary
Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep. 2013;62:423-425.
This commentary examines unsafe injection practices in the United States and reviews a four-element approach to reduce risks.